Guy Martin

ReporterThe Pharma Letter

Guy Martin has been a journalist since 2008.

He writes about all areas of pharma and biotech, and related business news.

He has a special interest in emerging technologies leading to the development of personalized medicines, along with the changes this will bring to the pharmaceutical industry and beyond.

Reset all filters

Refine Search

Company Spotlight